Data from HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models
Authors:
- Dongsheng WangDWDongsheng Wang
- Guoqing QianGQGuoqing Qian
- Hongzheng ZhangHZHongzheng Zhang
- Kelly R. MaglioccaKMKelly R. Magliocca
- Sreenivas NannapaneniSNSreenivas Nannapaneni
- A.R.M. Ruhul AminAAA.R.M. Ruhul Amin
- Michael RossiMRMichael Rossi
- Mihir PatelMPMihir Patel
- Mark El-DeiryMEMark El-Deiry
- J. Trad WadsworthJWJ. Trad Wadsworth
- Zhengjia ChenZCZhengjia Chen
- Fadlo R. KhuriFKFadlo R. Khuri
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)